Atrovent

Product NDC: 53002-8410
Requested package NDC: 53002-8410-1
11-digit product format: 530028410
Labeler code: 53002
Product ID: 53002-8410_ae30f199-16cf-4645-8ca6-01afb7157083
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: ipratropium bromide
Dosage form: AEROSOL, METERED
Route: RESPIRATORY (INHALATION)
Labeler: RPK Pharmaceuticals, Inc.
Application: NDA021527
Marketing category: NDA
Marketing start: 2005-05-01
Marketing end: 0000-00-00
Substance: IPRATROPIUM BROMIDE
Active strength: 17 ug/1
Pharmacologic classes: Anticholinergic [EPC],Cholinergic Antagonists [MoA]
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	53002-8410	53002-8410-1	I	Inactivated by FDA		2026-08-03

Observed NDC auxiliary status history#

Observed captured status history: Rows come only from successfully parsed FDA auxiliary ZIP captures. They show the state present in that artifact, not a continuous regulatory timeline. Absence before, after, or between captures is not proof of status, and a known non-data HTTP 403 capture is preserved in backfill provenance but cannot produce a status row.

Historic NDC status page 1 of 1 · 2 matching rows.

Browse every current auxiliary row. · Browse the complete NDC auxiliary source catalog.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Archive	Snapshot	Source SHA-256
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	53002-8410	53002-8410-1	I	Inactivated by FDA		excluded / ndc_excluded.zip	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	53002-8410	53002-8410-1	I	Inactivated by FDA		excluded / ndc_excluded.zip	`9bebd1f3094a…`	`5416666fcb17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021527-001	ATROVENT HFA	IPRATROPIUM BROMIDE	0.021MG/INH	AEROSOL, METERED / INHALATION	AB	RLD, RS	2004-11-27

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
N021527-001	AB

Orange Book patents#

Current patent rows page 1 of 1 · 1 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N021527-001	8474447	2030-01-17		Drug product, Delist requested	2015-05-28

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N021527-001	ATROVENT HFA	0.021MG/INH	AEROSOL, METERED / INHALATION	RLD, RS	2004-11-27	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N021527-001	AB	1	`a50c72e98297…`

Observed Orange Book patent history#

Patent history page 1 of 2 · 53 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Coverage / status	Submission date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021527-001	8474447	2030-01-17	Drug product, Delist requested	2015-05-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021527-001	8474447	2030-01-17	Drug product, Delist requested	2015-05-28	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021527-001	8474447	2030-01-17	Drug product, Delist requested	2015-05-28	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021527-001	6739333	2020-05-26	Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021527-001	6983743	2020-05-26	Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021527-001	6739333	2020-05-26	Drug product		`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021527-001	6983743	2020-05-26	Drug product		`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021527-001	6739333	2020-05-26	Drug product		`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021527-001	6983743	2020-05-26	Drug product		`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021527-001	6739333	2020-05-26	Drug product		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021527-001	6983743	2020-05-26	Drug product		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021527-001	6739333	2020-05-26	Drug product		`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021527-001	6983743	2020-05-26	Drug product		`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021527-001	6739333	2020-05-26	Drug product		`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021527-001	6983743	2020-05-26	Drug product		`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N021527-001	8474447	2030-01-17	Drug product	2015-05-28	`6a51e52b5d6a…`

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Atrovent HFA	IPRATROPIUM BROMIDE	Boehringer Ingelheim Pharmaceuticals, Inc.	170e98ef-5560-4068-be7d-e649068eb884	2025-11-05	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021527 application number: NDA021527

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
9ccc399f-9de9-4e86-a0ca-d7a2e7c6c36c	Product name	2	20251106
d953267a-4ca0-4d44-91ad-712cdee8ab38	Product name	2	20250630
0a278166-c8aa-41b6-b4a5-6ac332bde76a	Product name	1	20230718
6ac73021-459f-435b-b6c5-8c7d6a50c021	Product name	2	20170404

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
53002-8410-1	2025-01-30	C162847	48780-1	9d75b9cf-f125-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use ATROVENT HFA safely and effectively. See full prescribing information for ATROVENT HFA. ATROVENT® HFA (ipratropium bromide HFA inhalation aerosol), for oral inhalation use Initial U.S. Approval: 2004
53002-8410-1	2023-06-08	C162847	48780-1	9d75b9cf-f125-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use ATROVENT HFA safely and effectively. See full prescribing information for ATROVENT HFA. ATROVENT® HFA (ipratropium bromide HFA inhalation aerosol), for oral inhalation use Initial U.S. Approval: 2004
53002-8410-1	2023-01-30	C162847	48780-1	9d75b9cf-f125-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use ATROVENT HFA safely and effectively. See full prescribing information for ATROVENT HFA. ATROVENT® HFA (ipratropium bromide HFA inhalation aerosol), for oral inhalation use Initial U.S. Approval: 2004
53002-8410-1	2020-12-17	C162847	48780-1	9d75b9cf-f125-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use ATROVENT HFA safely and effectively. See full prescribing information for ATROVENT HFA. ATROVENT® HFA (ipratropium bromide HFA inhalation aerosol), for oral inhalation use Initial U.S. Approval: 2004
53002-8410-1	2020-01-31	C162847	48780-1	9d75b9cf-f125-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use ATROVENT HFA safely and effectively. See full prescribing information for ATROVENT HFA. ATROVENT® HFA (ipratropium bromide HFA inhalation aerosol), for oral inhalation use Initial U.S. Approval: 2004

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
53002-8410-1	AtroventHFA	1 in 1 CARTON	AEROSOL, METERED	1		5
53002-8410-1	AtroventHFA	200 in 1 CANISTER	AEROSOL, METERED	200		5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
53002-8410	ATROVENT HFA (IPRATROPIUM BROMIDE) AEROSOL, METERED [RPK PHARMACEUTICALS, INC.]	5	Legacy NDC, 2 package rows	20230609_ae462cd6-615b-4f0d-ae6e-59007e7acab0.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
J697UZ2A9J	IPRATROPIUM BROMIDE	66985-17-9	IPRATROPIUM BROMIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
836368	Atrovent HFA 17 MCG/INHAL Metered Dose Inhaler, 200 Actuations	PSN	ae462cd6-615b-4f0d-ae6e-59007e7acab0	5
836343	ipratropium bromide 17 MCG/INHAL Metered Dose Inhaler, 200 Actuations	PSN	ae462cd6-615b-4f0d-ae6e-59007e7acab0	5
836368	200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler [Atrovent]	SBD	ae462cd6-615b-4f0d-ae6e-59007e7acab0	5
836343	200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler	SCD	ae462cd6-615b-4f0d-ae6e-59007e7acab0	5
836368	200 ACTUAT Atrovent HFA 0.017 MG/ACTUAT Metered Dose Inhaler	SY	ae462cd6-615b-4f0d-ae6e-59007e7acab0	5
836368	Atrovent 0.017 MG/ACTUAT Metered Dose Inhaler, 200 ACTUAT	SY	ae462cd6-615b-4f0d-ae6e-59007e7acab0	5
836368	Atrovent HFA 17 MCG per ACTUAT Metered Dose Inhaler, 200 ACTUAT	SY	ae462cd6-615b-4f0d-ae6e-59007e7acab0	5
836343	ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, 200 ACTUAT	SY	ae462cd6-615b-4f0d-ae6e-59007e7acab0	5
836343	ipratropium bromide 17 MCG/ACTUAT Metered Dose Inhaler, 200 ACTUAT	SY	ae462cd6-615b-4f0d-ae6e-59007e7acab0	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
53002-8410-1	53002841001	1 CANISTER in 1 CARTON (53002-8410-1) > 200 AEROSOL, METERED in 1 CANISTER	1 canister	2018-10-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Atrovent HFA - RPK Pharmaceuticals, Inc.	RPK Pharmaceuticals, Inc.	2023-06-07	HUMAN PRESCRIPTION DRUG LABEL	5